Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Merck

IBD Screen Of The Day: Analysts Expect Favorable Profits From These 3 Stocks

Two important components in the CAN SLIM investing guidelines are current accelerating quarterly earnings growth and annual earnings growth, the C and the A in CAN SLIM. Look for these components in the growth stocks you're buying or watching. One way to find stocks with these positive traits is to…

Investors Business Daily

Dow Jones Dives After Key Inflation Report

The Dow Jones Industrial Average dived 575 points Thursday after a key inflation reading, threatening to extend this week's losses.

Investors Business Daily

This Analyst Believes Seagen Is Evaluating Strategic Alternatives

Raymond James initiated coverage on Seagen Inc (NASDAQ:SGEN) at Outperform with a $220 target price. Citing the recent departure of the long-time Seagen CEO, Raymond James thinks that the Board of Directors is likely evaluating strategic alternatives for the company. The relationship with Merck & Company, Inc. (NYSE:MRK) has been long-standing. With Keytruda losing its patent…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Dow Jones Rallies As Nike Falls On Weak Sales Guidance

The Dow Jones Industrial Average rose 200 points Tuesday, looking to rebound from Monday's losses. Nike stock tumbled on weak guidance.

Investors Business Daily

Dow Jones Futures: What To Do In New Stock Market Rally; Nike Earnings Beat; Tesla Sales Up Next

Dow Jones futures were higher after Monday's stock market fall. Tesla sales are due out amid the new stock market rally.

Investors Business Daily

Dow Jones Slips After Bullish Week; Nike Slumps Ahead Of Earnings; Watch These Health Care Stocks Now

The Dow Jones and other major stock indexes were down modestly Monday afternoon after a bullish week. Small caps outperformed.

Investors Business Daily

All Major Indexes Above 21-Day Moving Averages; Big Pharma Still Going Strong

The Nasdaq composite is down 0.5% while the S&P 500 is off 0.1%.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Dow Jones Turns Positive; Two Blue Chip Medical Stocks Score Breakouts

Dow Jones leaders UnitedHealth and Merck both scored breakouts from buy points and led the upside among blue chips.

Investors Business Daily

Dow Jones Reverses Lower As Stock Market Rally Continues; 6 Top Stocks To Buy And Watch

The Dow Jones Industrial Average turned lower Monday as the stock market rally continues. Top stocks to buy and watch include AutoZone.

Investors Business Daily

Stock Market Closes Higher, Snapping 3-Week Losing Streak; FedEx, Salesforce Lead Gains

The stock market closed higher Friday, snapping a 3-week losing streak on new data pointed to a slowing economy.

Investors Business Daily

Merck Discussing Another Drugmaker Buyout -- Buy Or Sell?

Merck & Co., Inc. (MRK) reported solid first-quarter results beating analysts’ estimates for sales and earnings. In addition, given that the company is in talks to acquire another biotech firm to boost its cancer-drug portfolio, would it be wise to buy the stock now? Let’s discuss.

StockNews.com

Dow Up Over 650 Points; Health Care, Biotechs The Winners This Week

The Nasdaq is on pace for a 6.4% gain for the week, while the S&P 500 is up 5.7%.

Investors Business Daily

Seagen Surges As Merck Takeover Deal Reportedly Accelerating

Merck is reportedly nearing a takeover of cancer biotech Seagen, according to a report Friday that prodded SGEN stock higher.

Investors Business Daily

Dow Jones Jumps In Broad Rally; Zendesk Spikes On Buyout, China Stocks Keep Rising

Futures rose, with crude oil and Treasury yields also up. Zendesk soared on a buyout. Li Auto, Alibaba led China stocks higher.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Merck/Seagen Potential Deal Talks Pick Up Speed: WSJ

Merck & Co Inc (NYSE:MRK) is pushing forward with a potential deal for Seagen Inc (NASDAQ:SGEN), Wall Street Journal reported, citing people familiar with the matter. The Journal mentioned that the deal could be one of the largest takeovers of the year. The Wall Street Journal reported last week that Merck was in talks to…

Investors Business Daily

Dow Jones Regains Upside As Nasdaq Leads; These Biotechs Near Buy Points

The Dow Jones reversed higher as several health care and biotech stocks outperformed.

Investors Business Daily

Stock Market Gains As Powell Continues Testimony; Health Care Stocks Outperform

The stock market gained as low jobless claims numbers pointed to a tight job market in spite of ongoing recession fears.

Investors Business Daily

Dow Jones Fades Gains Into Close After Powell's Recession Warning

Indexes were on track to close higher Wednesday but slipped back into the negative near the end of the session.

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Recap of Tuesday's Biotech Catalysts - End of the Day Summary

Ionis (NASDAQ: IONS) announced that Eplontersen met co-primary and secondary endpoints in interim analysis of the Phase 3 NEURO-TTRansform study for hereditary transthyretin-mediated amyloid polyneuropathy (ATTRv-PN) Ionis shares are trading low 4 percent at $35.10 in the after-hours session

Benzinga

SVB Leerink's Pro-forma Analysis Of Speculated Merck/Seagen Deal - What Investors Need To Know

SVB Securities conducted a pro-forma analysis of the financial impact to Merck & Co Inc (NYSE: MRK) from a potential acquisition of Seagen Inc (NASDAQ: SGEN).

Benzinga

Merck To Start Pivotal Trial For Next-Gen Pneumococcal Vaccine Next Month

Merck & Co Inc (NYSE:MRK) presented results from the Phase 1/2 study, evaluating V116 in pneumococcal vaccine-naïve adults 18-49 years of age (Phase 1) and 50 years of age and older (Phase 2). Data were shared at the International Symposium on Pneumococci and Pneumococcal Diseases. V116 targets serotypes that account for 85% of…

Investors Business Daily

Stock Market Closes Higher, But Dow Jones Inches Down; Exxon And Chevron Lead Oil Stocks Lower

The stock market gained but the Dow Jones inched lower on the eve of three-day weekend. Oil stocks tumble.

Investors Business Daily

Stock Market Ending Week With Gains But Energy Stocks Continue To Slide

Crude oil futures have fallen nearly 7% today, to $109 per barrel.

Investors Business Daily

Embattled Biotech Seagen Rockets On Rumors Merck Could Buy It

Merck is reportedly eyeing a takeover of embattled biotech Seagen, according to multiple reports that sent SGEN stock flying Friday.

Benzinga

Merck Shows Takeover Interest In Seagen: WSJ

Merck & Co Inc (NYSE:MRK) is reportedly mulling buying cancer-focused biotech Seagen Inc (NASDAQ:SGEN), Wall Street Journal reported citing people familiar with the matter. If the deal happens, it would be significant, given Seagen's market value of roughly $28 billion. According to the report, some people said other unnamed suitors are also eying Seagen, a…

1 … 18 19 20 21

People

Jerome Powell

3,134 stories

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.